Background and Objectives D‐negative red cells are transfused to D‐negative females of
childbearing potential (CBP) to prevent haemolytic disease of the foetus and newborn …

The use of blood products to resuscitate injured and massively bleeding patients in the
prehospital and early in-hospital phase of the resuscitation is increasing. Using group O red …

Abstract Background and Objectives The limited supply and increasing demand of group O
RhD‐negative red blood cells (RBCs) have resulted in other transfusion strategies being …

Background A risk assessment model for predicting the risk of haemolytic disease of the
fetus and newborn (HDFN) in future pregnancies following the transfusion of Rh (D)‐positive …

Background Evidence indicates the life‐saving benefits of early blood product transfusion in
severe trauma resuscitation. Many of these products will be RhD‐positive, so understanding …

Background The use of blood products early in the resuscitation of bleeding trauma patients
is widely accepted, but made difficult by limited supplies of D− red blood cell (RBC) …

Massive hemorrhage is the leading preventable cause of death during military operations.
During these operations, the delay between initial treatment and arrival at a surgical facility …

Background After the transfusion of RhD-positive red blood cell (RBC)-containing products
to an RhD-negative woman of childbearing potential (WCP) during trauma resuscitation …

Background: Whole blood transfusion is associated with benefits including improved
survival, coagulopathy, and decreased transfusion requirements. The majority of whole …

Recent research demonstrates that transfusing whole blood (WB= red blood cells (RBC)+
plasma+ platelets) rather than just RBC (which is current National Health Service (NHS) …